A

Abdullakoya

Active Director Additional Director DIN 10481428
DIN 10481428 First appointment Feb 2024 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdullakoya

Data last updated:

Abdullakoya is an Additional Director at Irnz Finzcure Pharmaceuticals Private Limited (since 2024). The company operates in Service.

DIN 10481428
Primary Designation Additional Director
Industry Service
First Appointment 08 Feb 2024
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director08 Feb 20242018Active

Board colleagues of Abdullakoya

NameDINCompanyDesignation
Lubaiba Keezhillath10475502Irnz Finzcure Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Irnz Finzcure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdullakoya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdullakoya

Abdullakoya currently holds 1 directorship: Irnz Finzcure Pharmaceuticals Private Limited (Additional Director, since 08 Feb 2024).

Abdullakoya was first appointed on 08 Feb 2024 as Additional Director at Irnz Finzcure Pharmaceuticals Private Limited.

The current boards of Abdullakoya's companies include Lubaiba Keezhillath (Irnz Finzcure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available